GC Biopharma Corp. (KRX:006280)
South Korea · Delayed Price · Currency is KRW 132,300
+3,000 (2.32%)
At close: Oct 2, 2025
GC Biopharma Market Cap
GC Biopharma has a market cap or net worth of 1.51 trillion as of October 6, 2025. Its market cap has decreased by -14.12% in one year.
Market Cap
1.51T
Enterprise Value
2.73T
Revenue
1.79T
Ranking
n/a
PE Ratio
20.45
Stock Price
132,300.00
Market Cap Chart
Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.51T, an increase of 5,079.65%. That is a compound annual growth rate of 14.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 1,506.54B | -26.46% |
| Dec 30, 2024 | 2,048.67B | 43.03% |
| Dec 28, 2023 | 1,432.35B | -3.09% |
| Dec 29, 2022 | 1,478.01B | -40.60% |
| Dec 30, 2021 | 2,488.07B | -46.31% |
| Dec 30, 2020 | 4,633.75B | 206.42% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |